"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
Descriptor ID |
D008113
|
MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1995 | 3 | 3 | 6 |
1996 | 4 | 1 | 5 |
1997 | 6 | 0 | 6 |
1998 | 7 | 1 | 8 |
1999 | 3 | 1 | 4 |
2000 | 6 | 2 | 8 |
2001 | 16 | 2 | 18 |
2002 | 10 | 2 | 12 |
2003 | 10 | 3 | 13 |
2004 | 8 | 6 | 14 |
2005 | 10 | 8 | 18 |
2006 | 11 | 4 | 15 |
2007 | 8 | 3 | 11 |
2008 | 14 | 4 | 18 |
2009 | 17 | 2 | 19 |
2010 | 10 | 8 | 18 |
2011 | 16 | 5 | 21 |
2012 | 22 | 1 | 23 |
2013 | 15 | 4 | 19 |
2014 | 17 | 2 | 19 |
2015 | 15 | 7 | 22 |
2016 | 17 | 5 | 22 |
2017 | 19 | 2 | 21 |
2018 | 18 | 6 | 24 |
2019 | 18 | 2 | 20 |
2020 | 17 | 1 | 18 |
2021 | 21 | 2 | 23 |
2022 | 26 | 0 | 26 |
2023 | 37 | 0 | 37 |
2024 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases. Radiol Oncol. 2024 Mar 01; 58(1):33-42.
-
Hepatic Arterial Infusion Chemotherapy for Unresectable HCC: Ready for Primetime? Acad Radiol. 2024 Mar; 31(3):844-845.
-
Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur). BMC Cancer. 2024 Feb 13; 24(1):201.
-
Transarterial Radioembolization for Management of Hepatocellular Carcinoma. Oncologist. 2024 Feb 02; 29(2):117-122.
-
Quantitative differences in volumetric calculations for radiation dosimetry in segmental Y90 treatment planning using hybrid angiography-CT compared with anatomic segmentation. Br J Radiol. 2024 Feb 02; 97(1154):353-362.
-
Establishing the clinical relevance of grade A post-hepatectomy liver failure. J Surg Oncol. 2024 Mar; 129(4):745-753.
-
Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials. Int J Radiat Oncol Biol Phys. 2024 Apr 01; 118(5):1519-1530.
-
Implementation of a liver health check in people with type 2 diabetes. Lancet Gastroenterol Hepatol. 2024 Jan; 9(1):83-91.
-
Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids. PLoS Pathog. 2023 Dec; 19(12):e1011887.
-
ASO Visual Abstract: Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy-An International Survey of the HAI Consortium Research Network. Ann Surg Oncol. 2023 12; 30(13):8021-8022.